Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Eribulin Mesilate Injection

Approval Number

国药准字H20249579

Company成都西岭源药业有限公司

Registration Date

December 1, 2024

Drug Information

Generic Name

甲磺酸艾立布林注射液

Dosage Form

注射剂

Strength

2ml:1mg

Drug Type

化学药品

Registration Date

December 1, 2024

Company Information

Applicant Company

Company Name成都西岭源药业有限公司

Company Address

四川省成都高新区科园南路88号天府生命科技园C1楼（孵化楼）8层805号

Manufacturing Company

Company Name健进制药有限公司

Company Address

成都高新综合保税区科新路8号附9号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

甲磺酸艾立布林注射液 - NMPA 批准文号 | MedPath